Feed aggregator |
Hiring and Retaining Talent: Three Es for Creating an Attractive Work Environment
The Payoff from Investing in Pricing Capabilities
Accenture Wins $73 Million Energy Supply Chain Integration Contract
Chevron to Explore Three China Deepwater Sites
Former HP CEO Named Oracle Co-president
Dollar Falls to 15-year Low Against Yen
Web-Bargain Luxury Comes to Japan
India Court Rules Against Vodafone
Global-Bank Deal Targets Reserves
Mercedes-Benz India Car Sales Surge
GGP to Start New CEO Hunt
Biggest Battles in Biopharma
You know the picture: Two pharma CEOs, shaking hands and smiling as cameras flash and video rolls. It's been common enough, especially recently, as Pfizer and Wyeth, Merck and Schering-Plough announced their big mergers.
But that's not always the way M&A goes. While many pharma deals over the past 20 years have been relatively friendly, others haven't. Hostile bids, media grandstanding, warring press releases--unfriendly mergers have triggered them all.
The following list includes some of the biggest battles of the last two decades. We've covered a few of them ourselves, but others are before our time, such as Pfizer's Warner-Lambert takeover. Click below to get all the details on some of the industry's biggest takeover battles.
Click here to get started

Recent comments
11 weeks 1 day ago